Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination topical wound dressing comprised of **bismuth tribromophenolate (also referred to as bismuth tribromophenate) at 3%** and **petrolatum (petroleum jelly)**, usually applied as an impregnated mesh gauze. The best-known commercial name is **Xeroform**. This dressing is used for its **occlusive, non-adherent barrier properties** to maintain wound moisture, prevent desiccation, and protect against mechanical trauma. **Bismuth tribromophenolate**—a halogenated phenol-metal complex—has demonstrated *bacteriostatic* and deodorizing properties in vitro, potentially disrupting microbial metabolic processes by releasing bismuth ions, although clinical studies suggest that antimicrobial efficacy in the Xeroform petrolatum preparation is limited. **Petrolatum** forms the main occlusive, nonadherent base, supporting a moist wound-healing environment. **Primary uses** (indications): superficial or partial-thickness burns, donor and graft sites, abrasions, lacerations, surgical wounds, and wounds healing by secondary intention. The dressing is valued for biocompatibility, patient comfort (due to non-adherence), flexibility to body contours, ease of removal, and ability to be produced inexpensively from basic components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bismuth tribromophenolate + petrolatum.